Commentary · 21 Feb 2026
Conference abstractPublished 20 Oct 2014
Cancer stem cell: A new paradigm shift in silibinin efficacy to control colorectal cancer
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Colorectal cancer (CRC) is second leading cause of cancer-related deaths in US. Cancer stem cells (CSC), now recognized as main cause for initiation, promotion and progression of CRC, are inherently resistant to chemo- and radio-therapies which has been the major cause of failure to most of the current therapies. Thus, discovery and development of agents, especially chemopreventive agents, which also target both ?initiated? stem cells and colon CSC, might provide better opportunities to control CRC at both early and advanced stages. We have recently reported the strong preventive and therapeutic efficacy of silibinin in different CRC pre-clinical models. Accordingly, here we assessed silibinin effect on colon CSC and associated mechanisms. The growth kinetics and cycling properties of colon CSC enriched spheres indicated a significant but differential inhibitory effect of silibinin on three different human CRC cell lines. Differentiation assays of these spheroids under serum conditions indicated the formation of more differentiated clones by silibinin treatment. Mechanistic studies showed that silibinin significantly decreases CSC marker CD44 mRNA expression, Notch-mediated signaling, and protein levels of cleaved Notch and its transcriptional target Hes-1. The implications of such an effect are tremendous, since the disruption of homeostasis (regulated in part by Notch signaling) among stem cells and progenitor cells in intestinal region results in the expansion of CSC pool together with an increase in proliferative cell populations.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Rajesh Agarwal”
